|
1
|
American Cancer Society. Key Statistics
for Pancreatic Cancer. https://www.cancer.org/content/dam/CRC/PDF/Public/8778.00.pdf.
Accessed February 20, 2022.
|
|
2
|
Zhang L, Sanagapalli S and Stoita A:
Challenges in diagnosis of pancreatic cancer. World J
Gastroenterol. 24:2047–2060. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Poruk KE, Firpo MA, Adler DG and Mulvihill
SJ: Screening for pancreatic cancer: Why, how, and who? Ann Surg.
257:17–26. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Globocan: Global Cancer Statistics in
Mexico. Journal 2021: 2020. https://gco.iarc.fr/today/data/factsheets/populations/484-mexico-fact-sheets.pdf.
Accessed December 2021.
|
|
5
|
Yachida S, Jones S, Bozic I, Antal T,
Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al:
Distant metastasis occurs late during the genetic evolution of
pancreatic cancer. Nature. 467:1114–1117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Asai Y, Itoi T, Sugimoto M, Sofuni A,
Tsuchiya T, Tanaka R, Tonozuka R, Honjo M, Mukai S, Fujita M, et
al: Elevated polyamines in saliva of pancreatic cancer. Cancers
(Basels). 10(43)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ballehaninna UK and Chamberlain RS: The
clinical utility of serum CA 19-9 in the diagnosis, prognosis and
management of pancreatic adenocarcinoma: An evidence based
appraisal. J Gastrointest Oncol. 3:105–119. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
O'Neill RS and Stoita A: Biomarkers in the
diagnosis of pancreatic cancer: Are we closer to finding the golden
ticket? World J Gastroenterol. 27:4045–4087. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chang CY, Huang SP, Chiu HM, Lee YC, Chen
MF and Lin JT: Low efficacy of serum levels of CA 19-9 in
prediction of malignant diseases in asymptomatic population in
Taiwan. Hepatogastroenterology. 53:1–4. 2006.PubMed/NCBI
|
|
10
|
Hartwig W, Strobel O, Hinz U, Fritz S,
Hackert T, Roth C, Büchler MW and Werner J: CA19-9 in potentially
resectable pancreatic cancer: Perspective to adjust surgical and
perioperative therapy. Ann Surg Oncol. 20:2188–2196.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wingren C, Sandström A, Segersvärd R,
Carlsson A, Andersson R, Löhr M and Borrebaeck CA: Identification
of serum biomarker signatures associated with pancreatic cancer.
Cancer Res. 72:2481–2490. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hermida Lazcano I, Sánchez Tejero E, Nerín
Sánchez C, Cordero Bernabé R, Mora Escudero I and Pinar Sánchez J:
Tumor markers. Marcadores Tumorales. Rev Clín Med Fam. 9:31–42.
2016.
|
|
13
|
Goonetilleke KS and Siriwardena AK:
Systematic review of carbohydrate antigen (CA 19-9) as a
biochemical marker in the diagnosis of pancreatic cancer. Eur J
Surg Oncol. 33:266–270. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Menéndez-Sánchez P, Villarejo-Campos P,
Padilla-Valverde D, Menéndez-Rubio JM and Rodríguez-Montes JA:
Tumor markers in colorectal cancer. Cir Cir. 81:169–175.
2013.PubMed/NCBI(In Spanish).
|
|
15
|
Tellez-Avila F, García-Osogobio S and
Residente R: The carcinoembryonic antigen: by the way a well-known
friend. Rev Invest Clin. 57:814–819. 2005.(In Spanish).
|
|
16
|
Irigoyen Oyarzabal AM, Amiguet García JA,
López Vivanco G, Genollá Subirats J, Muñoz Villafranca MC,
Ojembarrena Martínez E and Liso Irurzun P: Tumoral markers and
acute-phase reactants in the diagnosis of pancreatic cancer.
Gastroenterol Hepatol. 26:624–629. 2003.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
17
|
Guasco Herrera C, Chávez Servín JL, Ferriz
Martínez RA, de la Torre Carbot K, Elton Puente E and García Gasca
T: Polyamines: Little Giants of Metabolic Regulation. REB.
33:51–57. 2014.(In Spanish).
|
|
18
|
Wallace HM, Fraser AV and Hughes A: A
perspective of polyamine metabolism. Biochem J. 376(Pt 1):1–14.
2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Medina MA, Quesada AR, Núñez de Castro I
and Sánchez-Jiménez F: Histamine, polyamines, and cancer. Biochem
Pharmacol. 57:1341–1344. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Madan M, Patel A, Skruber K, Geerts D,
Altomare DA and Iv OP: ATP13A3 and caveolin-1 as potential
biomarkers for difluoromethylornithine-based therapies in
pancreatic cancers. Am J Cancer Res. 6:1231–1252. 2016.PubMed/NCBI
|
|
21
|
Niemi RJ, Roine AN, Häkkinen MR,
Kumpulainen PS, Keinänen TA, Vepsäläinen JJ, Lehtimäki T, Oksala NK
and Mäenpää JU: Urinary polyamines as biomarkers for ovarian
cancer. Int J Gynecol Cancer. 27:1360–1366. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kawakita M, Hiramatsu K, Yanagiya M, Doi Y
and Kosaka M: Determination of N¹,N¹²-diacetylspermine in urine: A
novel tumor marker. Methods Mol Biol. 720:367–378. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Umemori Y, Ohe Y, Kuribayashi K, Tsuji N,
Nishidate T, Kameshima H, Hirata K and Watanabe N: Evaluating the
utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in
urine as tumor markers for breast and colorectal cancers. Clin Chim
Acta. 411:1894–1899. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Takahashi Y, Sakaguchi K, Horio H,
Hiramatsu K, Moriya S, Takahashi K and Kawakita M: Urinary N1,
N12-diacetylspermine is a non-invasive marker for the diagnosis and
prognosis of non-small-cell lung cancer. Br J Cancer.
113:1493–1501. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong
WT, Ng CF and Wong KL: Urinary Polyamines: A pilot study on their
roles as prostate cancer detection biomarkers. PLoS One.
11(e0162217)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sugimoto M, Wong DT, Hirayama A, Soga T
and Tomita M: Capillary electrophoresis mass spectrometry-based
saliva metabolomics identified oral, breast and pancreatic
cancer-specific profiles. Metabolomics. 6:78–95. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Soda K: The mechanisms by which polyamines
accelerate tumor spread. J Exp Clin Cancer Res.
30(95)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Massaro C, Thomas J and Phanstiel Iv O:
Investigation of polyamine metabolism and homeostasis in pancreatic
cancers. Med Sci (Basel). 5(32)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Venza M, Visalli M, Cicciu D and Teti D:
Determination of polyamines in human saliva by high-performance
liquid chromatography with fluorescence detection. J Chromatogr B
Biomed Sci Appl. 757:111–117. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cruz-Galvez CC, Ortiz-Lazareno PC,
Pedraza-Brindis EJ, Villasenor-Garcia MM, Reyes-Uribe E,
Bravo-Hernandez A, Solis-Martinez RA, Cancino-Marentes M,
Rodriguez-Padilla C, Bravo-Cuellar A and Hernandez-Flores G:
Pentoxifylline enhances the apoptotic effect of carboplatin in Y79
retinoblastoma cells. In Vivo. 33:401–412. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shmulewitz D, Aharonovich E, Witkiewitz K,
Anton RF, Kranzler HR, Scodes J, Mann KF, Wall MM and Hasin D:
Alcohol Clinical Trials Initiative (ACTIVE Group). The World Health
Organization Risk Drinking Levels Measure of Alcohol Consumption:
Prevalence and Health Correlates in Nationally Representative
Surveys of U.S. Adults, 2001-2002 and 2012-2013. Am J Psychiatry.
178:548–559. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lukic S, Mijac D, Filipovic B,
Sokic-Milutinovic A, Tomasevic R, Krstic M and Milosavljevic T:
Chronic abdominal pain: Gastroenterologist approach. Dig Dis.
40:181–186. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
McNamara KM, Gobert AP and Wilson KT: The
role of polyamines in gastric cancer. Oncogene. 40:4399–4412.
2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Holbert CE, Cullen MT, Casero RA Jr and
Stewart TM: Polyamines in cancer: Integrating organismal metabolism
and antitumour immunity. Nat Rev Cancer. 22:467–480.
2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kenner BJ, Chari ST, Maitra A, Srivastava
S, Cleeter DF, Go VL, Rothschild LJ and Goldberg AE: Early
detection of pancreatic cancer-a defined future using lessons from
other cancers: A white paper. Pancreas. 45:1073–1079.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li Y, Li Y and Huang C: Circulating miRNAs
Increasing the Risk of Cancer. In: Cancer and Noncoding RNAs.
Chakrabarti J and Mitra S (eds). Vol. 1. Academic Press, Boston,
pp79-94, 2018.
|
